The FDA issues a warning to Johnson & Johnson’s COVID vaccine label about a rare risk of Guillain-Barré syndrome. Post navigation GM kills wireless charging in Suburban, Tahoe and Denali over chip shortage – Roadshow Twitter mistakenly verifies fake accounts – CNET
Alibaba’s Metis agent cuts redundant AI tool calls from 98% to 2% — and gets more accurate doing it Apr 30, 2026
